SARS-CoV-2 causes severe respiratory symptoms and can lead to significant morbidity and mortality, particularly in older adults and those with underlying health issues.
The virus’s mutations create challenges for treatment, highlighting the need for flexible medical strategies.
The review focuses on the roles of vitamin D, calcium, and parathormone in potentially affecting COVID-19 progression, advocating for a comprehensive understanding to improve patient outcomes.